Hammerberg O, Bialkowska-Hobrzanska H, Gregson D, McGhie K, Behme R
Department of Microbiology and Infectious Diseases, St. Joseph's Health Centre, London, Ontario, Canada.
Eur J Clin Microbiol Infect Dis. 1995 Mar;14(3):199-205. doi: 10.1007/BF02310356.
Three neonates and three other patients located elsewhere in the hospital became infected with Staphylococcus aureus. Initial automated microdilution susceptibility testing with oxacillin and disk diffusion testing with amoxicillin-clavulanic acid indicated the isolates had borderline oxacillin resistance (MICs 4 micrograms/ml), presumably due to hyperproduction of beta-lactamase. Chromosomal DNA restriction fingerprinting and phage typing revealed the neonatal isolates to be identical; whereas, the other patients were infected with three different strains. Further analysis of the four strains by Southern hybridization with a mecA specific oligoprobe and a quantitative beta-lactamase assay demonstrated that two strains carried the mecA gene (coding for low affinity penicillin-binding protein 2a), and two strains were hyperproducers of beta-lactamase, including one which was mecA gene positive. One strain neither carried the mecA gene nor hyperproduced beta-lactamase. The two mecA gene positive strains displayed oxacillin MICs of 16 micrograms/ml on dilution susceptibility testing in 4% NaCl supplemented Mueller-Hinton agar. Hence, they were considered intrinsically methicillin-resistant Staphylococcus aureus. Both oxacillin and amoxicillin-clavulanic acid MICs were increased on NaCl supplementation. Results of amoxicillin-clavulanic acid disk diffusion susceptibility testing did not correlate with quantitative beta-lactamase production. It is recommended that clinical laboratories do not use amoxicillin-clavulanic acid disk diffusion assays to differentiate suspected borderline resistance due to beta-lactamase hyperproduction from mecA gene expression of PBP-2a since additional mechanisms may account for resistance.
三名新生儿以及医院其他地方的三名患者感染了金黄色葡萄球菌。最初用苯唑西林进行的自动微量稀释药敏试验以及用阿莫西林-克拉维酸进行的纸片扩散试验表明,分离株对苯唑西林具有临界耐药性(最低抑菌浓度为4微克/毫升),推测是由于β-内酰胺酶超量产生所致。染色体DNA限制性指纹图谱分析和噬菌体分型显示,新生儿分离株是相同的;而其他患者感染的是三种不同的菌株。通过用mecA特异性寡核苷酸探针进行Southern杂交以及定量β-内酰胺酶测定对这四种菌株进行进一步分析表明,两种菌株携带mecA基因(编码低亲和力青霉素结合蛋白2a),两种菌株是β-内酰胺酶超量产生菌,其中一种是mecA基因阳性。一种菌株既不携带mecA基因,也不超量产生β-内酰胺酶。在添加4%氯化钠的穆勒-欣顿琼脂中进行稀释药敏试验时,两种mecA基因阳性菌株的苯唑西林最低抑菌浓度为16微克/毫升。因此,它们被认为是固有耐甲氧西林金黄色葡萄球菌。添加氯化钠后,苯唑西林和阿莫西林-克拉维酸的最低抑菌浓度均升高。阿莫西林-克拉维酸纸片扩散药敏试验的结果与定量β-内酰胺酶产生情况不相关。建议临床实验室不要使用阿莫西林-克拉维酸纸片扩散试验来区分因β-内酰胺酶超量产生引起的疑似临界耐药性与PBP-2a的mecA基因表达,因为可能还有其他耐药机制。